Lee Chul-woo, a senior researcher at the International Vaccine Research Institute, said, “Vaccines value representation, so we conduct clinical trials according to the gender ratio as close as possible to 5:5.”Can you safely prevent disease?Since is the first goal, it is practically difficult to consider gender-specific responses at the development stage.
Those who are angry just at the title of the article